Clinical Trial Update: Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of early combined therapy with PCSK9 inhibitors and statins in acute ischemic stroke has completed Phase 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Xiang Luo | Conditions: Acute Ischemic Stroke | Phase 2, Phase 3 | Status: COMPLETED